Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Enteric Disease Testing Market (Amebiasis, C.difficile Infection, Campylobacteriosis, Cholera, Cryptosporidiosis, E.coli Infection, Giardiasis, H.pylori Infection, Norovirus Infection, Rotavirus Infection, Salmonellosis and Shigellosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Enteric Disease Testing Market (Amebiasis, C.difficile Infection, Campylobacteriosis, Cholera, Cryptosporidiosis, E.coli Infection, Giardiasis, H.pylori Infection, Norovirus Infection, Rotavirus Infection, Salmonellosis and Shigellosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Transparency <strong>Market</strong><br />
Research<br />
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>- <strong>Global</strong> <strong>Industry</strong><br />
<strong>Analysis</strong>, <strong>Size</strong>, <strong>Share</strong>, <strong>Growth</strong>, <strong>Trends</strong> <strong>and</strong> <strong>Forecast</strong>,<br />
<strong>2013</strong> - <strong>2019</strong><br />
Published Date<br />
<strong>2013</strong>-09-24<br />
92 Page Report<br />
Buy Now<br />
Request Sample<br />
Press Release<br />
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong> to Witness Rapid <strong>Growth</strong> Owing to<br />
Rising Dem<strong>and</strong> from Asia Pacific <strong>and</strong> Africa<br />
Transparency <strong>Market</strong> Research<br />
State Tower,<br />
90, State Street, Suite 700.<br />
Albany, NY 12207<br />
United States<br />
www.transparencymarketresearch.com<br />
sales@transparencymarketresearch.com
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
REPORT DESCRIPTION<br />
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong> - <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong>, <strong>Size</strong>, <strong>Share</strong>, <strong>Growth</strong>,<br />
<strong>Trends</strong> <strong>and</strong> <strong>Forecast</strong>, <strong>2013</strong> <strong>–</strong> <strong>2019</strong><br />
According to a new research study published by Transparency <strong>Market</strong> Research, titled “<strong>Enteric</strong><br />
<strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong> - <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong>, <strong>Size</strong>, <strong>Share</strong>, <strong>Growth</strong>, <strong>Trends</strong> <strong>and</strong> <strong>Forecast</strong>, <strong>2013</strong><br />
- <strong>2019</strong>”, the global enteric disease testing market, which was valued at US$3.1 billion in 2012 is<br />
expected to be worth US$3.6 billion in <strong>2019</strong>, growing at a CAGR of 2.4% during the forecast<br />
period from <strong>2013</strong> to <strong>2019</strong>.<br />
<strong>Enteric</strong> diseases are the most common causes of mortality <strong>and</strong> morbidity worldwide. High<br />
incidence of infectious enteric diseases is noted especially in developing countries owing to poor<br />
drainage <strong>and</strong> sanitation systems <strong>and</strong> lack of awareness about hygiene in these overpopulated<br />
countries. The report analyzes the global enteric disease testing market for 12 major types,<br />
which includes amebiasis, campylobacteriosis, cryptosporidiosis, giardiasis, salmonellosis, <strong>and</strong><br />
clostridium difficile mediated infection. People generally tend to overlook the mild symptoms<br />
exhibited by these diseases, which if not treated on time may lead to severe complications,<br />
possibly resulting in death. Therefore, early diagnosis of the disease is of utmost importance to<br />
have a speedy recovery. The most common symptoms exhibited by the disease include stomach<br />
pain, high fever, diarrhea, nausea, weight loss, vomiting, <strong>and</strong> anorexia.<br />
Browse the full <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong> Report @ :<br />
http://www.transparencymarketresearch.com/enteric-disease-testingmarket.html<br />
The report studies <strong>and</strong> analyzes the global enteric disease testing market, focusing on the wide<br />
range of traditional as well as modern diagnostic kits used for diagnosing the diseases. It<br />
conducts an in-depth research on the facts instrumental in spearheading the paradigm shift from<br />
culture tests that relied on fecal samples to rapid tests such as EIA (enzyme immunoassaya) <strong>and</strong><br />
PCR (polymerase chain reaction). This change in conventions of disease testing can be attributed<br />
Transparency <strong>Market</strong> Research<br />
2
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
to the advent of newer medical testing methods that offer a range of advantages over their<br />
precursors. For instance, both PCR <strong>and</strong> EIA tests offer enhanced specificity <strong>and</strong> accuracy, <strong>and</strong><br />
provide quick results as compared to culture testing.<br />
The report highlights that under the influence of growing awareness <strong>and</strong> increasing dem<strong>and</strong> for<br />
point of care testing, the global enteric disease testing market will grow at a CAGR of 2.4% from<br />
<strong>2013</strong> to <strong>2019</strong>. In order to provide clarity in research observation, the report has segmented the<br />
global market for enteric disease testing into the bacterial enteric disease testing market <strong>and</strong> the<br />
viral enteric disease market on the basis of types of disease. Geographically, the market has<br />
been segmented into North America, Asia Pacific, Europe, Africa, Latin America, <strong>and</strong> Rest of the<br />
World (RoW).<br />
Browse the full <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong> press release @ :<br />
http://www.transparencymarketresearch.com/pressrelease/entericdisease-testing-market.htm<br />
According to the report, rising incidence of enteric diseases in developing countries in Asia Pacific<br />
<strong>and</strong> Africa is one of the major factors driving the dem<strong>and</strong> for quick tests in the global market.<br />
Continuously improving healthcare infrastructure, government initiatives adopted to promote<br />
health <strong>and</strong> wellness, <strong>and</strong> rising number of healthcare facilities in these regions have bolstered<br />
growth of the global enteric disease testing market.<br />
Get Free Sample Report <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong> :<br />
http://www.transparencymarketresearch.com/sample/sample.php?<br />
flag=S&rep_id=1258<br />
Transparency <strong>Market</strong> Research<br />
3
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
In order to study the market dynamics, the report has profiled the major players in the market<br />
such as Biomerica, DiaSorin, Alere, Trinity Biotech, Meridian Bioscience, Bio-Rad, Cepheid, Becton<br />
Dickinson, <strong>and</strong> bioMerieux.<br />
TABLE OF CONTENT<br />
Chapter 1 Preface<br />
1.1 Report Description<br />
1.2 <strong>Market</strong> Segmentation: <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong><br />
1.3 Research Methodology<br />
1.3.1 Sources<br />
1.3.1.1 Secondary Research<br />
1.3.1.2 Primary Research<br />
1.4 Assumptions And Intimations<br />
Chapter 2 Executive Summary<br />
2.1 <strong>Market</strong> Introduction<br />
2.2 Comparison <strong>Analysis</strong> By Geography: <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong> (2012 & <strong>2019</strong>)<br />
Chapter 3 <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong> Overview<br />
3.1 <strong>Enteric</strong> <strong>Disease</strong>s<br />
3.2 Rise of Rapid <strong>Testing</strong> for <strong>Enteric</strong> <strong>Disease</strong>s<br />
3.3 <strong>Market</strong> Dynamics<br />
Transparency <strong>Market</strong> Research<br />
4
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
3.3.1 Drivers<br />
3.3.1.1 Dem<strong>and</strong> for Rapid Diagnosis<br />
3.3.1.2 Untapped <strong>Market</strong> in Developing Countries<br />
3.3.1.3 Application of Molecular Diagnostics<br />
3.3.2 Restraints<br />
3.3.2.1 Lack of Awareness<br />
3.3.2.2 Mild <strong>and</strong> Asymptomatic <strong>Disease</strong>s<br />
3.3.3 Opportunities<br />
3.3.3.1 Increasing Opportunities in Molecular Diagnostics Based <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong><br />
3.3.3.2 Developing Nations will be Highly Lucrative <strong>Market</strong>s<br />
3.4 Porters Five Forces <strong>Analysis</strong> for <strong>Global</strong> <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
3.4.1 Bargaining Power of Suppliers<br />
3.4.2 Bargaining Power of Buyers<br />
3.4.3 Threat from Substitutes<br />
3.4.4 Threat from New Entrants<br />
3.4.5 Degree of Competitive Rivalry<br />
3.5 <strong>Market</strong> Attractiveness for <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Geography, 2012<br />
Chapter 4 <strong>Global</strong> <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
4.1 Bacterial <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
4.1.1 Clostridium Difficile Infection<br />
Transparency <strong>Market</strong> Research<br />
5
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
4.1.1.1 Epidemiology<br />
4.1.1.2 Diagnostic Tests <strong>and</strong> <strong>Market</strong> Overview<br />
4.1.2 Campylobacteriosis<br />
4.1.2.1 Epidemiology<br />
4.1.2.2 Diagnostic Tests <strong>and</strong> <strong>Market</strong> Overview<br />
4.1.3 Cholera<br />
4.1.3.1 Epidemiology<br />
4.1.3.2 Diagnostic Tests <strong>and</strong> <strong>Market</strong> Overview<br />
4.1.4 E.Coli <strong>Enteric</strong> <strong>Disease</strong>s<br />
4.1.4.1 Epidemiology<br />
4.1.4.2 Diagnostic Tests <strong>and</strong> <strong>Market</strong> Overview<br />
4.1.5 Helicobacter Pylori <strong>Enteric</strong> <strong>Disease</strong>s<br />
4.1.5.1 Epidemiology<br />
4.1.5.2 Diagnostic Tests <strong>and</strong> <strong>Market</strong> Overview<br />
4.1.6 Salmonellosis<br />
4.1.6.1 Epidemiology<br />
4.1.6.2 Diagnostic Tests <strong>and</strong> <strong>Market</strong> Overview<br />
4.1.7 Shigellosis<br />
4.1.7.1 Epidemiology<br />
4.1.7.2 Diagnostic Tests <strong>and</strong> <strong>Market</strong> Overview<br />
4.2 Viral <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
Transparency <strong>Market</strong> Research<br />
6
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
4.2.1 Rotavirus<br />
4.2.1.1 Epidemiology<br />
4.2.1.2 Diagnostic Tests <strong>and</strong> <strong>Market</strong> Overview<br />
4.2.2 Norovirus <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong><br />
4.2.2.1 Epidemiology<br />
4.2.2.2 Diagnostic Tests <strong>and</strong> <strong>Market</strong> Overview<br />
4.3 Parasitic <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
4.3.1 Amebiasis<br />
4.3.1.1 Epidemiology<br />
4.3.1.2 Diagnostic Tests <strong>and</strong> <strong>Market</strong> Overview<br />
4.3.2 Cryptosporidiosis<br />
4.3.2.1 Epidemiology<br />
4.3.2.2 Diagnostic Tests <strong>and</strong> <strong>Market</strong> Overview<br />
4.3.3 Giardiasis<br />
4.3.3.1 Epidemiology<br />
4.3.3.2 Diagnostic Tests <strong>and</strong> <strong>Market</strong> Overview<br />
Chapter 5 <strong>Global</strong> <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
5.1 Introduction<br />
5.1.1 North America<br />
Transparency <strong>Market</strong> Research<br />
7
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
Million)<br />
5.1.1.1 North America <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD<br />
5.1.2 Europe<br />
5.1.2.1 Europe <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD Million)<br />
5.1.3 Asia-Pacific<br />
Million)<br />
5.1.3.1 Asia-Pacific <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD<br />
5.1.4 Africa<br />
5.1.4.1 Africa <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD Million)<br />
5.1.5 Latin America<br />
Million)<br />
5.1.5.1 Latin America <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD<br />
5.1.6 Rest Of The World<br />
Million)<br />
5.1.6.1 Rest of the World <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD<br />
Chapter 6 Key Player <strong>Analysis</strong> for <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, 2012<br />
Chapter 7 Company Profiles<br />
7.1 Alere, Inc.<br />
7.1.1 Company Overview<br />
7.1.2 Financial Overview<br />
Transparency <strong>Market</strong> Research<br />
8
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
7.1.3 Product Portfolio<br />
7.1.4 Business Strategies<br />
7.1.5 Recent Developments<br />
7.2 Becton Dickinson & Company<br />
7.2.1 Company Overview<br />
7.2.2 Financial Overview<br />
7.2.3 Product Portfolio<br />
7.2.4 Business Strategies<br />
7.2.5 Recent Developments<br />
7.3 Biomerica, Inc.<br />
7.3.1 Company Overview<br />
7.3.2 Financial Overview<br />
7.3.3 Product Portfolio<br />
7.3.4 Recent Developments<br />
7.4 Biomerieux<br />
7.4.1 Company Overview<br />
7.4.2 Financial Overview<br />
7.4.3 Product Portfolio<br />
7.4.4 Business Strategies<br />
7.4.5 Recent Developments<br />
7.5 Bio-Rad<br />
Transparency <strong>Market</strong> Research<br />
9
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
7.5.1 Company Overview<br />
7.5.2 Financial Overview<br />
7.5.3 Product Portfolio<br />
7.5.4 Business Strategies<br />
7.6 Cepheid<br />
7.6.1 Company Overview<br />
7.6.2 Financial Overview<br />
7.6.3 Product Portfolio<br />
7.6.4 Business Strategies<br />
7.6.5 Recent Developments<br />
7.7 Coris Bioconcept<br />
7.7.1 Company Overview<br />
7.7.2 Financial Overview<br />
7.7.3 Product Portfolio<br />
7.7.4 Recent Developments<br />
7.8 Diasorin<br />
7.8.1 Company Overview<br />
7.8.2 Financial Overview<br />
7.8.3 Product Portfolio<br />
7.8.4 Business Strategies<br />
7.8.5 Recent Developments<br />
Transparency <strong>Market</strong> Research<br />
10
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
7.9 Meridian Bioscience, Inc.<br />
7.9.1 Company Overview<br />
7.9.2 Financial Overview<br />
7.9.3 Product Portfolio<br />
7.9.4 Business Strategies<br />
7.9.5 Recent Developments<br />
7.10 Quest Diagnostics<br />
7.10.1 Company Overview<br />
7.10.2 Financial Overview<br />
7.10.3 Product Portfolio<br />
7.10.4 Business Strategies<br />
7.10.5 Recent Developments<br />
7.11 Trinity Biotech<br />
7.11.1 Company Overview<br />
7.11.2 Financial Overview<br />
7.11.3 Product Portfolio<br />
7.11.4 Business Strategies<br />
7.11.5 Recent Developments<br />
List of Figures<br />
FIG. 1 <strong>Market</strong> Segmentation: <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong><br />
Transparency <strong>Market</strong> Research<br />
11
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
FIG. 2 Comparison <strong>Analysis</strong>, By Geography (2012 & <strong>2019</strong>) <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
FIG. 3 Porter’s Five Forces <strong>Analysis</strong> For <strong>Global</strong> <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
FIG. 4 <strong>Market</strong> Attractiveness For <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Geography, 2012<br />
FIG. 5 <strong>Global</strong> Bacterial <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By <strong>Disease</strong> Type, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 6 <strong>Global</strong> Viral <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By <strong>Disease</strong> Type, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 7 <strong>Global</strong> Parasitic <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, 2011-<strong>2019</strong> (USD Million)<br />
FIG. 8 Alere: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 9 Becton Dickinson: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 10 Biomerica, Inc.: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 11 Biomerieux: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 12 Bio-Rad: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 13 Cepheid: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 14 Diasorin: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 15 Meridian Bioscience, Inc.: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 16 Quest Diagnostics: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
FIG. 17 Trinity Biotech: Annual Sales Revenue, USD Million, 2010 <strong>–</strong> 2012<br />
List of Tables<br />
TABLE 1 <strong>Market</strong> Snapshot: <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> Products<br />
TABLE 2 <strong>Global</strong> <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 3 <strong>Global</strong> C.Difficile Infection <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
Transparency <strong>Market</strong> Research<br />
12
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
TABLE 4 <strong>Global</strong> Campylobacteriosis <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 5 <strong>Global</strong> Cholera <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 6 <strong>Global</strong> E.Coli Infection <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 7 <strong>Global</strong> H.Pylori Infection <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 8 <strong>Global</strong> Salmonellosis <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 9 <strong>Global</strong> Shigellosis <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 10 <strong>Global</strong> Rotavirus Infection <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 11 <strong>Global</strong> Norovirus Infection <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 12 <strong>Global</strong> Amebiasis <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 13 <strong>Global</strong> Cryptosporidiosis <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 14 <strong>Global</strong> Giardiasis <strong>Testing</strong> <strong>Market</strong>, By Geography, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 15 North America <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types Of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 16 Europe <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types Of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 17 Asia-Pacific <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types Of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 18 Africa <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types Of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 19 Latin America <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types Of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD Million)<br />
TABLE 20 Rest of the World <strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong>, By Types Of <strong>Disease</strong>s, 2011 - <strong>2019</strong> (USD<br />
Million)<br />
Browse All Pharmaceutical <strong>Market</strong> Research Reports @<br />
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html<br />
About Us<br />
Transparency <strong>Market</strong> Research<br />
13
<strong>Enteric</strong> <strong>Disease</strong> <strong>Testing</strong> <strong>Market</strong><br />
Transparency <strong>Market</strong> Research is a market intelligence company providing global business information<br />
reports <strong>and</strong> services. Our exclusive blend of quantitative forecasting <strong>and</strong> trends analysis provides forwardlooking<br />
insight for thous<strong>and</strong>s of decision makers.<br />
We are privileged with highly experienced team of Analysts, Researchers <strong>and</strong> Consultants, who use<br />
proprietary data sources <strong>and</strong> various tools <strong>and</strong> techniques to gather, <strong>and</strong> analyze information. Our<br />
business offerings represent the latest <strong>and</strong> the most reliable information indispensable for businesses to<br />
sustain a competitive edge.<br />
Contact<br />
Transparency <strong>Market</strong> Research<br />
90 State Street,<br />
Suite 700,<br />
Albany<br />
NY - 12207<br />
United States<br />
Tel: +1-518-618-1030<br />
USA - Canada Toll Free 866-552-3453<br />
Email: sales@transparencymarketresearch.com<br />
Website: http://www.transparencymarketresearch.com/<br />
Browse The <strong>Market</strong> Research Blog :<br />
http://research<strong>and</strong>reports.wordpress.com/ http://www.transparencymarketresearch.com<br />
Transparency <strong>Market</strong> Research<br />
14
Change language